EVEX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
EVEX is not a good buy right now for a beginner long-term investor with $50,000-$100,000 available. The stock has speculative upside from eVTOL commercialization, but the current price action is weak, the business is still loss-making, and there is no strong Intellectia proprietary buy signal today. I would not call this an immediate buy; the better call is to hold off.
Technically, EVEX is still in a bearish setup. The MACD histogram is negative at -0.0808 and remains below zero, showing weak momentum. RSI_6 at 32.985 is near oversold but not yet a clear reversal signal. The moving average structure is bearish with SMA_200 > SMA_20 > SMA_5, which confirms a downtrend. Price at 2.70 is below the pivot of 3.016 and only slightly above support at 2.63, with deeper support at 2.392. That means the stock is sitting close to support, but the trend has not turned up yet. Similar-pattern analysis also suggests limited near-term upside and weaker one-month performance.
Latest quarter shown: Q1 2026. Eve reported a net loss of $68.8 million, driven by higher R&D spending as it develops eVTOL aircraft. That means the company is still in a heavy investment phase, with losses expected as it works toward certification and commercialization. The financial profile supports a long-duration growth story, but it does not yet show strong near-term earnings strength.
Analyst sentiment is mixed but still somewhat constructive. Canaccord keeps a Buy rating but trimmed its target to $7.25 from $7.50. JPMorgan remains Overweight but lowered the target to $6 from $7. Cantor Fitzgerald also kept Overweight while cutting the target to $6 from $7. Goldman Sachs is the most cautious with a Neutral rating and a target cut to $4.70 from $5.28. Overall, Wall Street sees a long-term story with real upside, but pros are clearly lowering expectations and becoming more conservative on timing and ramp-up.
